SHH:600329
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited · SHH · Healthcare · CNY · FY for 2025
Figures on this page computed 2026-11-08 13:32 UTC
Last close
n/aCNY
Market data
15.2xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- computed
- Computed from the filing for 2025
34.4%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
43.3%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
7.0%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
0.01Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
3.0%Dividend yield
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- computed
What it pays out is the furthest below its sector's middle: 0.40 against 0.44 on the market's range.
Follow one yuan
lens 1 of 9After what it costs to make
74.0%
After running the business
50.6%
After interest and tax
43.3%
After what it must reinvest
7.0%
Kept after the dividend
-13.0%
The five stops
5 of 5 read- After what it costs to make3,639,925,56174.0%
- After running the business2,489,590,32350.6%
- After interest and tax2,131,021,53643.3%
- After what it must reinvest342,452,9147.0%
- Kept after the dividend-638,832,874-13.0%
Of every unit of sales, -0.13 is still there after the dividend.
Of every unit of sales, -0.13 is still there after the dividend.
Every figure in this lens
Except where said otherwise: Computed from the filing for 2025
Sales4,917,335,979
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
After what it costs to make3,639,925,561
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
After running the business2,489,590,323
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
After interest and tax2,131,021,536
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
After what it must reinvest342,452,914
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
Kept after the dividend-638,832,874
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY